An unusual lawsuit filed last month sheds light on a scientific misconduct investigation into a prominent
cardiac stem cell lab.
Not exact matches
Starting in 2007, in the same French Institute of Health and Medical Research (INSERM)
lab where he did his Ph.D., Catelain worked to harness the potential of embryonic
stem cells for treating
cardiac diseases.
In
lab experiments, the researchers isolated exosomes from specialized human
cardiac stem cells and found that exosomes alone had the same beneficial effects as
stem cells.
Gladstone scientists have discovered how to make the three types of heart
cells — cardiomyocytes, endothelial
cells, and smooth muscle
cells — out of a new type of
cardiac stem cell created in a
lab.